News Conference News HVS 2025 Solid Durability Seen With Surgical Resilia Tissue Aortic Valve Yael L. Maxwell April 21, 2025
News Conference News TCT 2024 ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients Todd Neale October 30, 2024
News Conference News TCT 2024 ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation Yael L. Maxwell October 29, 2024
News Conference News TCT 2024 Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT Michael O'Riordan October 27, 2024
News Conference News EuroPCR 2024 Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY Michael O'Riordan May 17, 2024
News Conference News AATS 2023 Beware High-Risk TAVI in Patients With Low-Lying Coronaries Michael O'Riordan May 11, 2023
News Conference News PCR London Valves 2022 Registry Results See Less PVL, Pacemakers With Acurate neo2 Shelley Wood November 29, 2022
News Conference News PCR London Valves 2022 Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains Shelley Wood November 28, 2022
News Conference News EuroPCR 2022 Better Durability With Self-Expanding TAVI? Clues From UK TAVI Shelley Wood May 18, 2022
News Conference News EuroPCR 2022 JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use Caitlin E. Cox May 18, 2022
News Conference News PCR London Valves 2021 Good Results but Small Numbers With JenaValve Trilogy in Severe AR Michael O'Riordan November 26, 2021
News Conference News TCT 2019 Predicting Final Valve Position After TAVR: Different Devices, Different Success Michael O'Riordan October 07, 2019